1287. Pharmacokinetics, Safety, and Tolerability of Nacubactam after Single Coadministration with β-Lactams in Japanese Healthy Subjects

por Asano, Masayo, Sato, Hiroki, Morita, Jun, Ishiwata, Kazuya, Kondo, Kenichiro
Publicado 2020

628. Pharmacokinetics, Safety and Tolerability of Co-administration of Nacubactam and β-lactams after Multiple Doses in Japanese Healthy Subjects

por Sato, Hiroki, Morita, Jun, Miura, Tatsuo, Sumiya, Masayo, Takaya, Risako, Kondo, Kenichiro
Publicado 2021

2136. In Vitro Activity of Nacubactam (OP0595) Combined with Cefepime against Carbapenem-resistant Enterobacterales Isolated in Japan

por Yanagihara, Katsunori, Mikamo, Hiroshige, Tateda, Kazuhiro, Doi, Yohei, Ohge, Hiroki, Takahashi, Satoshi, Kondo, Kenichiro
Publicado 2023

1379. Determination of the Arbekacin Exposure Required to Prevent Amplification of Resistant Subpopulations Using Patient Pharmacokinetics Simulated in a Hollow-Fiber Infection Mod...

por VanScoy, Brian D, Lakota, Elizabeth A, Bhavnani, Sujata M, Giesel, Greg, Carranco, Ana I, Nagira, Yu, Ouchi, Shohei, Kondo, Kenichiro, Ambrose, Paul G
Publicado 2018

1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection

por Bhavnani, Sujata M, Hammel, Jeffrey P, Lakota, Elizabeth A, VanScoy, Brian D, Nagira, Yu, Rubino, Christopher M, Sato, Nobuo, Koresawa, Tomokazu, Kondo, Kenichiro, Ambrose, Paul G
Publicado 2018